1. © Coronary Artery Disease In Saudi Arabia Al-Nozha, MM; Arafah, MR; Al-Mazrou, YY; Al-Maatouq, MA; Khan, NB; Khalil, MZ; Al-Khadra, AH; Al-Marzouki, K; Abdullah, MA; Al-Harthi, SS; Al- Shahid, MS; Nouh, MS; Al-Mobeireek, A SAUDI MED J, SAUDI MEDICAL JOURNAL; pp: 1165-1171; Vol: 25 King Fahd University of Petroleum & Minerals http://www.kfupm.edu.sa Summary Objectives: Coronary artery disease (CAD) is a major public health problem worldwide. To our knowledge, there is no national data available from community based studies on prevalence of CAD in the Kingdom of Saudi Arabia (KSA). Therefore, we designed this study with the objective to determine the prevalence of CAD among Saudis of both sexes, between the ages of 30-70-years in rural as well as urban communities. Further, to determine the prevalence and clinical pattern of the major modifiable risk factors for CAD among the same population. This work is part of a major national study on CAD in Saudis Study (CADISS). Methods: This is a community based study conducted by examining subjects in the age group of 30-70- years of selected households during 5-year period between 1995 and 2000 in KSA. Data were obtained from history using a validated questionnaire, and electrocardiography. The data were analyzed to provide prevalence of CAD and risk assessment model. Results: Nine hundred and forty-four subjects, out of 17232 were diagnosed to have CAD. Thus, the overall prevalence of CAD obtained from this study is 5.5% in KSA. The prevalence in males and females were 6.6% and 4.4% (P < 0.0001). Urban Saudis have a higher prevalence of 6.2% compared to rural Saudis of 4% (P < 0.0001). The following variables are found to be statistically significant risk factors in KSA: age, male gender, body mass index (BMI), hypertension, current smoking, fasting blood glucose, fasting cholesterol and triglycerides. Conclusions: The overall prevalence of CAD in KSA is 5.5%. A national prevention program at community level as well as high risk groups should be implemented sooner to prevent Copyright: King Fahd University of Petroleum & Minerals; http://www.kfupm.edu.sa

2. 1. 2. 3. 4. 5. 6. 7. © the expected epidemic of CAD that we are seeing, beginning. Measures are needed to change lifestyle and to address the management of the metabolic syndrome, to reduce modifiable risk factors for CAD. A longitudinal study is needed to demonstrate the importance of reducing modifiable risk factors for CAD in KSA. References: 2002, CIRCULATION, V106, P3143 *AM HEART ASS, 1994, HEART STROK FACTS S *CDCP NAT CTR HLTH, 1994, NAT HLTH EX SURV 3 N *CENTR DEP STAT, 2001, STAT YB, P50 *WHO MONICA PROJ P, 1988, J CLIN EPIDEMIOL, V41, P105 ABALKHAIL BA, 2000, PREV MED, V31, P390 ALMEDA FQ, 2004, AM J MED, V116, P112, DOI 10.1016/j.amjmed.2003.09.029 8. ALWAN A, 1995, EMRO TECHNICAL PUBLI, P22 9. ANAND SS, 2000, LANCET, V356, P279 10. ARONOW WS, 2003, GERIATRICS, V58, P18 11. ARONOW WS, 2003, GERIATRICS, V58, P26 12. ARONOW WS, 2003, GERIATRICS, V58, P31 13. ARVIND K, 2002, INDIAN J MED RES, V116, P163 14. BECKLES GLA, 1986, LANCET, V1, P1298 15. BLACKBURN H, 1960, CIRCULATION, V21, P1160 16. CASTELLI WP, 1984, AM J MED, V76, P4 17. COHN PF, 2003, CIRCULATION, V108, P1263, DOI 18. 10.1161/01.CIR.0000088001.59265.EE 19. DEEDWANIA PC, 1991, ARCH INTERN MED, V151, P2373 20. DHAWAN J, 1996, CURR OPIN LIPIDOL, V7, P196 21. DOWNS JR, 1998, JAMA-J AM MED ASSOC, V279, P1615 22. ENAS EA, 1992, AM J CARDIOL, V70, P945 23. ERIKSSEN J, 1977, EUR J CARDIOL, V6, P285 24. FREEDMAN SB, 2002, P 14 WORLD C CARD 20 25. GENEST JJ, 1992, CIRCULATION, V85, P2025 26. GINSBERG HN, 2003, AM J CARDIOL S, V91, E29, DOI 27. 10.1016/S0002-9149(02)03386-6 28. GRUNDY SM, 1999, CIRCULATION, V100, P1134 29. HUNG J, 1990, LANCET, V336, P261 30. HUNINK MGM, 1997, JAMA-J AM MED ASSOC, V277, P535 31. INOGUCHI T, 2000, DIABETES RES CLIN PR, V47, P37 32. KANNEL W, 1979, CIRCULATION, V59, P2035 33. KORTELAINEN ML, 2002, INT J OBESITY, V26, P73 34. KROLEWSKI AS, 1987, AM J CARDIOL, V59, P750 35. LAMARCHE B, 1996, CIRCULATION, V94, P273 36. LAMPE FC, 1998, EUR HEART J, V19, P63 Copyright: King Fahd University of Petroleum & Minerals; http://www.kfupm.edu.sa

3. 37. 38. 39. 40. 41. 42. 43. 44. 45. 46. 47. 48. 49. 50. 51. 52. 53. 54. 55. 56. 57. 58. 59. 60. 61. © LINTON MF, 2003, AM J CARDIOL, V92, I19, DOI 10.1016/S0002-9149(03)00505-8 MCKEIGUE PM, 1992, BRIT HEART J, V67, P341 MENOTTI A, 2003, EUR J EPIDEMIOL, V18, P113 MEYER LC, 1994, DIABETIC MED, V11, P670 MIURA K, 2001, ARCH INTERN MED, V161, P1501 MOHAN V, 2001, J AM COLL CARDIOL, V38, P682 PRESCOTT E, 1998, BRIT MED J, V316, P1043 RAJADURAI J, 1992, AUST NZ J MED, V22, P345 ROSE G, 1977, BRIT J PREV SOC MED, V31, P42 SACKS FM, 1996, NEW ENGL J MED, V335, P1001 SCOTT CL, 2003, AM J CARDIOL, V92, I35, DOI 10.1016/S0002-9149(03)00507-1 SHAH SN, 1999, J OKLA STATE MED ASS, V92, P267 SHAUKAT N, 1994, POSTGRAD MED J, V70, P318 SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301 SINGH RB, 1995, J AM COLL NUTR, V14, P628 SOEDAMAHMUTHU SS, 2004, DIABETES CARE, V27, P530 STAMLER J, 1993, DIABETES CARE, V16, P434 THOM TJ, 1998, INCIDENCE PREVALENCE, P3 TRACY RP, 2003, INT J CLIN PRACT S, V134 VASAN RS, 2002, CIRCULATION, V105, P48 WOLK R, 2003, CIRCULATION, V108, P2206, DOI 10.1161/01.CIR.0000095270.85646.E8 YEOLEKAR ME, 1998, J POSTGRAD MED, V44, P26 For pre-prints please write to: malnozha@hotmail.com Copyright: King Fahd University of Petroleum & Minerals; http://www.kfupm.edu.sa